Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5′monophosphate in asthmatic patients
- 1 October 2005
- journal article
- clinical trial
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 18 (5) , 328-336
- https://doi.org/10.1016/j.pupt.2005.01.004
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Population Pharmacokinetics and Pharmacodynamics of CiclesonideThe Journal of Clinical Pharmacology, 2003
- Pharmacokinetics of ciclesonide and its active principle in asthma patients and healthy subjects after single-dose inhalationJournal of Allergy and Clinical Immunology, 2003
- Inhaled Corticosteroids and Hip FractureAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Adverse skin reactions to inhaled corticosteroidsExpert Opinion on Drug Safety, 2002
- Long‐term outcomes in paediatric asthmaAllergy, 2002
- Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionateJournal of Paediatrics and Child Health, 2002
- Inhaled corticosteroid use and bone-mineral density in patients with asthmaThe Lancet, 2000
- A Dose-dependent Effect of the Novel Inhaled Corticosteroid Ciclesonide on Airway Responsiveness to Adenosine-5 ′ -Monophosphate in Asthmatic PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Systemic Adverse Effects of Inhaled Corticosteroid TherapyArchives of internal medicine (1960), 1999
- Inhaled Corticosteroids and CataractDrug Safety, 1999